Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
Marcus Maurer, Luís Felipe Ensina, Ana M. Giménez‐Arnau, Gordon Sussman et autres
69 citationsThe Lancet